Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab and Sumatriptan Interaction Study
NCT02741310Phase 1Completed
- Sponsor
- Amgen
- Start
- Feb 2016
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in migraine comparing Placebo with Erenumab (2 arms). Primary endpoint: Time-weighted Averages of Mean Arterial Pressure at Day 5. Started Feb 2016; status: completed.
02
Drugs
erenumab
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02741310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741310.